ALDH7A1 and epilepsy: Therefore, we propose that our patient exemplifies a paradigm of non-canonical pyridoxine-dependent epilepsy—a condition exhibiting the clinical hallmarks of true PDE (pharmacoresistance, dramatic PN response, dependence for seizure control) without mutations in known PN metabolism genes.